{"id":"W4324136640","doi":"10.1200/jco.2023.41.6_suppl.332","title":"Real-world use of darolutamide, enzalutamide, and apalutamide for non-metastatic castration-resistant prostate cancer (DEAR).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bayer (Canada)","funders":"Bayer HealthCare","keywords":"Enzalutamide; Medicine; Prostate cancer; Internal medicine; Clinical endpoint; Adverse effect; Oncology; Cancer; Androgen receptor; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00182876,0.0001829628,0.0003432964,0.0008269335,0.0003843862,0.0007666379,0.0005826601,0.0003417549,0.001604764],"category_scores_gemma":[0.005559368,0.0003233083,0.0005960813,0.001751356,0.0002701884,0.0006200062,0.0005956628,0.0005965357,0.0003263104],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001131021,"about_ca_system_score_gemma":0.001407886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008470229,"about_ca_topic_score_gemma":0.01312083,"domain_scores_codex":[0.9974434,0.0007468414,0.0005303257,0.000578775,0.0005706649,0.000130005],"domain_scores_gemma":[0.989813,0.001246618,0.007817529,0.0003732092,0.000459843,0.0002897465],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009455534,0.0001815314,0.987817,0.0005233401,0.0003159209,0.0001685533,0.0001849678,0.0001466976,0.00021585,0.00008858482,0.001762299,0.007649632],"study_design_scores_gemma":[0.000189378,0.0007350222,0.9910271,0.000192709,0.0002913426,0.00110366,0.0003617945,0.0006925093,0.000314601,0.00009337489,0.004974652,0.00002398312],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9643176,0.002969338,0.0007977537,0.0002275277,0.00002729571,0.0005285916,0.02891516,0.00002770678,0.002189129],"genre_scores_gemma":[0.9857156,0.001088999,0.001018778,0.0002781604,0.00004102933,0.000388731,0.01114877,0.00001190097,0.0003081397],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008470229,"threshold_uncertainty_score":0.01684189,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2401466883066312,"score_gpt":0.5210510775349937,"score_spread":0.2809043892283625,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}